Press "esc" to clear
Go to Advanced Search

Showing results

110 of 492
20171212-IMG_7462.jpg

Article ID: 697684

UK Researchers Study New Therapy to Treat Opioid Use Disorder

University of Kentucky

The study compared the performance of weekly and monthly CAM2038, with the current standard of care, a daily sublingual dose of buprenorphine/naloxone. Results showed the drug’s non-inferiority on the primary responder rate outcome, which was based upon highly sensitive urine testing detecting illicit opioids. The data suggests that injectable buprenorphine is efficacious and may have advantages.

Released:
20-Jul-2018 9:30 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
donhelme1v2.jpg

Article ID: 697679

UK Communication Professor Seeks Drug Disposal Solutions

University of Kentucky

UK researcher Don Helme is partnering with the Kentucky Attorney General’s office to gauge public opinion on a new drug deactivation pouch, part of a larger effort to develop solutions to the state’s opioid epidemic. Four counties have received Deterra, the deactivation pouch.

Released:
19-Jul-2018 4:15 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Social and Behavioral Sciences

  • Embargo expired:
    19-Jul-2018 4:00 PM EDT

Article ID: 697476

AJPH September Issue: Black Lung on the Rise, Opioid Deaths by Congressional District, Police Violence and More

American Public Health Association (APHA)

In this issue, find research on black lung, opioids, police violence and more.

Released:
16-Jul-2018 2:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Joy.Buck.feature.jpg

Article ID: 697642

Researcher Investigates Risk for Opioid Overdose in Rural West Virginia

West Virginia University

Based at West Virginia University’s Eastern Campus in Martinsburg, Joy Buck, a WVU School of Nursing professor, and her collaborators will gather real-time data about overdose trends and assess the cultural barriers to—and facilitators of—overdose prevention. The findings gleaned from her pilot project may prove useful in other rural areas across the nation.

Released:
19-Jul-2018 10:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 697621

Prolonged Opioid Use Before Knee or Hip Replacement Surgery Increases Risk of Poor Outcomes

Wolters Kluwer Health: Lippincott Williams and Wilkins

Patients who take prescription opioids for more than 60 days before total knee or hip replacement surgery are at significantly higher risk of being readmitted to the hospital and of undergoing repeat joint-replacement surgery, compared to patients with no preoperative opioid use, reports a study in the July 18 issue of The Journal of Bone & Joint Surgery. The journal is published in the Lippincott portfolio in partnership with Wolters Kluwer.

Released:
18-Jul-2018 3:30 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 697605

Expert Alert: Physician Anesthesiologist Available to Discuss Drug Shortages, Medication Rationing and Disruption of Patient Care

American Society of Anesthesiologists (ASA)

Released:
18-Jul-2018 1:40 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites

Article ID: 697580

American Pain Society Statement on Research, Funding and Opioids

American Pain Society

New and innovative pain treatments to replace opioids will not be discovered unless pain research funding becomes a priority on Capitol Hill. The APS Pain Research Agenda, published in the Journal of Pain in 2014, states “the most direct path to achieving dramatic advances in pain treatment is through substantially increased investment in pain research and education, which would enable the pursuit of an aggressive translational pain-research agenda.”

Released:
18-Jul-2018 8:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 697508

Researchers Show Impact of Outdoor Behavioral Healthcare More Lasting

University of New Hampshire

Mental health and substance abuse issues in adolescents have become major societal problems, forcing parents and health providers to look for innovative treatment options that may better suit some teens. However, some proven therapy programs, like Outdoor Behavioral Healthcare (OBH), can be challenging to access because many are not covered by insurance companies – creating an enormous cost burden for parents. Now, a landmark study by researchers at the University of New Hampshire has found that parents of youth who went through an outdoor behavioral program report that their children showed almost three times the improvement after one year than youth who remained in their communities for more traditional treatment.

Released:
17-Jul-2018 8:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Social and Behavioral Sciences

Article ID: 697359

In Medicaid Patients, High Opioid Doses and Concurrent Sedative Use Are Risk Factors for Fatal Opioid Overdose

Wolters Kluwer Health: Lippincott Williams and Wilkins

Among Medicaid recipients taking prescription opioids, high opioid doses and concurrent treatment with benzodiazepine sedatives are among the key, potentially modifiable risk factors for fatal overdose, reports a study in the August issue of Medical Care. The journal is published in the Lippincott portfolio by Wolters Kluwer.

Released:
12-Jul-2018 12:30 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
OTPInfographic_Image.png

Article ID: 697350

Study Reveals Opioid Patients Face Multiple Barriers To Treatment

Vanderbilt University Medical Center

In areas of the country disproportionately affected by the opioid crisis, treatment programs are less likely to accept patients paying through insurance of any type or accept pregnant women, a new Vanderbilt study found.

Released:
12-Jul-2018 11:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

110 of 492





Chat now!